Cancer Med May 2018 PMID 29573568

Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy.

Giulia Lori, Paolo Paoli, Anna Caselli, Paolo Cirri, Riccardo Marzocchini, Monica Mangoni, Cinzia Talamonti, Lorenzo Livi, Giovanni Raugei

Full text PDF Download social card

Mentions

Peak: 1 in Sep 2019

across 2 sources since Sep 2019

Extended reach

1,272

potential audience

Total likes

Video views

Mentions per month

Sep 2019 – Jun 2023

Where it's discussed

X / Twitter1 posts
YouTube1 videos

AI synopsis

What people are saying

The discussions mention the therapeutic potential of targeting LMW-PTP, with some users highlighting the significance of combining such strategies with existing treatments, as seen in phrases like 'sensitize melanoma cells' and 'boost their effectiveness.' The tone reflects cautious optimism, with focus on the scientific implications and possible future clinical benefits, but without overly strong endorsements or dismissals.

AgreementNeither agree nor disagree

The posts show a neutral stance, neither strongly supporting nor opposing the research findings.

InterestModerate interest

The discussions indicate a mild curiosity, especially around the potential applications in cancer therapy.

EngagementModerate engagement

Participants reference the methodology and possible clinical implications, showing some depth of engagement.

ImpactNeutral impact

Overall, the impact appears moderate; the discussions recognize potential but do not suggest immediate widespread influence.

Abstract in brief

Silencing of LMWPTP enhances the sensitivity of melanoma cells (A375) and prostate cancer cells (PC3) to chemotherapy drugs like dacarbazine, 5FU, and radiotherapy, leading to increased cancer cell death.
The study shows that Morin, a LMWPTP inhibitor, can synergize with anticancer treatments to boost their effectiveness without harming normal cells, both in laboratory experiments and animal models.
Targeting LMWPTP may be a promising strategy to overcome drug resistance in melanoma treatment, potentially providing a new adjuvant approach to improve patient outcomes.

Read the full abstract

All mentions

Enhancing Melanoma Therapy by Targeting LMWPTP Enzyme

Social RTCL TV · Jun 28, 2023 20 views

@RadOncPapers

@radoncpapers · X

Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy. https://t.co/z5LNhfJ37Z H/T @NCBI #radonc #PubMed

Sep 7, 2019 · 1,253 followers View post →